These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9127460)

  • 21. Changes in urinary excretion of type-I collagen cross-linked C-telopeptide and N-telopeptide in perimenopausal women.
    Taga M; Shirashu K; Minaguchi H
    Horm Res; 1998; 49(2):86-90. PubMed ID: 9485177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis.
    Garnero P; Borel O; Delmas PD
    Clin Chem; 2001 Apr; 47(4):694-702. PubMed ID: 11274020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High bone turnover is associated with low bone mass in both pre- and postmenopausal women.
    Ravn P; Fledelius C; Rosenquist C; Overgaard K; Christiansen C
    Bone; 1996 Sep; 19(3):291-8. PubMed ID: 8873970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy.
    Christgau S; Bitsch-Jensen O; Hanover Bjarnason N; Gamwell Henriksen E; Qvist P; Alexandersen P; Bang Henriksen D
    Bone; 2000 May; 26(5):505-11. PubMed ID: 10773591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N; Juillet F; Garnero P
    Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surface plasmon resonance detection of interactions between peptide fragments of N-telopeptide and its monoclonal antibodies.
    Lung FD; Chen CH; Liou CC; Chen HY
    J Pept Res; 2004 Apr; 63(4):365-70. PubMed ID: 15102054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of serum and urinary C-terminal telopeptide of type I collagen in aging, menopause and osteoporosis.
    Kawana K; Takahashi M; Hoshino H; Kushida K
    Clin Chim Acta; 2002 Feb; 316(1-2):109-15. PubMed ID: 11750280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different responses of free and peptide-bound cross-links to vitamin D and calcium supplementation in elderly women with vitamin D insufficiency.
    Kamel S; Brazier M; Rogez JC; Vincent O; Maamer M; Desmet G; Sebert JL
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3717-21. PubMed ID: 8855828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum crosslaps in comparison to serum osteocalcin and urinary bone resorption markers.
    Peichl P; Griesmacherb A; Marteau R; Hejc S; Kumpan W; Müller MM; Bröll H
    Clin Biochem; 2001 Mar; 34(2):131-9. PubMed ID: 11311223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
    Garnero P; Gineyts E; Schaffer AV; Seaman J; Delmas PD
    Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of bone disease using isomerized and racemized fragments of type I collagen.
    Cloos PA; Fledelius C; Christgau S; Christiansen C; Engsig M; Delmas P; Body JJ; Garnero P
    Calcif Tissue Int; 2003 Jan; 72(1):8-17. PubMed ID: 12384813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An immunoassay for measuring fragments of newly synthesized collagen type I produced during metastatic invasion of bone.
    Cloos PA; Lyubimova N; Solberg H; Qvist P; Christiansen C; Byrjalsen I; Christgau S
    Clin Lab; 2004; 50(5-6):279-89. PubMed ID: 15209436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cartilage turnover assessed with a newly developed assay measuring collagen type II degradation products: influence of age, sex, menopause, hormone replacement therapy, and body mass index.
    Mouritzen U; Christgau S; Lehmann HJ; Tankó LB; Christiansen C
    Ann Rheum Dis; 2003 Apr; 62(4):332-6. PubMed ID: 12634232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone.
    Garnero P; Fledelius C; Gineyts E; Serre CM; Vignot E; Delmas PD
    J Bone Miner Res; 1997 Sep; 12(9):1407-15. PubMed ID: 9286756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine.
    Gertz BJ; Shao P; Hanson DA; Quan H; Harris ST; Genant HK; Chesnut CH; Eyre DR
    J Bone Miner Res; 1994 Feb; 9(2):135-42. PubMed ID: 8140926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.
    Garnero P; Hausherr E; Chapuy MC; Marcelli C; Grandjean H; Muller C; Cormier C; Bréart G; Meunier PJ; Delmas PD
    J Bone Miner Res; 1996 Oct; 11(10):1531-8. PubMed ID: 8889854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): follow-up on hormone replacement therapy and osteoporosis risk assessment.
    Bonde M; Qvist P; Fledelius C; Riis BJ; Christiansen C
    J Clin Endocrinol Metab; 1995 Mar; 80(3):864-8. PubMed ID: 7883844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption.
    Clemens JD; Herrick MV; Singer FR; Eyre DR
    Clin Chem; 1997 Nov; 43(11):2058-63. PubMed ID: 9365389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the menopause and hormone replacement therapy on the carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen.
    Hassager C; Risteli J; Risteli L; Christiansen C
    Osteoporos Int; 1994 Nov; 4(6):349-52. PubMed ID: 7696831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationships between the degree of beta-isomerization of type I collagen degradation products in the urine and aging, menopause and osteoporosis with fractures.
    Hoshino H; Takahashi M; Kushida K; Ohishi T; Inoue T
    Osteoporos Int; 1999; 9(5):405-9. PubMed ID: 10550459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.